Menu
The new sharewise is here Clearer, faster, with a light and a dark view — and everything you already know. Try it now
Microsoft strongly encourages users to switch to a different browser than Internet Explorer as it no longer meets modern web and security standards. Therefore we cannot guarantee that our site fully works in Internet Explorer. You can use Chrome or Firefox instead.
Price
Target price
€0.050

€0.050

-5.710%
-0.003
-5.710%
-
 
06.08.26 / Frankfurt WKN: A0EAWN / Name: AT / Stock / Pharmaceuticals / Micro Cap /
Please give a prediction to see the opinions of the community
sharewise uses Wisdom of crowds to gather information regarding a security. Wisdom of crowds works best if you do not see the predictions of others before giving your estimate. Please click one button to see how the community sees this security.

Allergy Therapeutics PLC Stock

Heavy losses for Allergy Therapeutics PLC today as the stock fell by -€0.003 (-5.710%).

Pros and Cons of Allergy Therapeutics PLC in the next few years

Pros
?
S********** s********
?
G***** c******* t* c**********
?
W********* I********* f** t** n*** y****
Cons
?
C******** o* t** e**********
?
M***** P*******
?
B****
Tell us your opinion to access the 'Wisdom of the Crowds'

Performance of Allergy Therapeutics PLC vs. its peers

Security Change(%) 1w 1m 1y YTD 3y 5y
Allergy Therapeutics PLC -5.710% -17.500% -30.282% -40.361% -57.692% 59.677% -84.434%
Beximco Pharmaceuticals Ltd. GDR 0.000% -2.830% 11.957% 10.515% 14.955% 28.109% -44.624%
Eledon Pharmaceuticals Inc. -2.030% 2.837% -14.201% -2.027% 126.563% 150.000% -46.296%
SELLAS Life Sciences Group Inc 1.970% 13.789% -16.803% 646.324% 258.025% 581.208% 35.695%

News

D-Wave Quantum Q2 Earnings Call HighlightsPhoto, wide shot, wide-angle lens, soft focus,  Pharmaceutical company, sunset photo at golden hour, photo by Peter Lik: https://oaidalleapiprodscus.blob.core.windows.net/private/org-IbuNdCATsFaPOITjFOv2kJh3/user-AXaxqjBUW45D8BadJEo9mUpW/img-TIgKJfhK8q44RPNTTsL9npu7.png?st=2023-05-08T05%3A58%3A04Z&se=2023-05-08T07%3A58%3A04Z&sp=r&sv=2021-08-06&sr=b&rscd=inline&rsct=image/png&skoid=6aaadede-4fb3-4698-a8f6-684d7786b067&sktid=a48cca56-e6da-484e-a814-9c849652bcb3&skt=2023-05-08T02%3A36%3A56Z&ske=2023-05-09T02%3A36%3A56Z&sks=b&skv=2021-08-06&sig=BDDjRcmCPf%2BH//HSxRGZYByMqOKev8lx0/Dhvka/lXk%3D
D-Wave Quantum Q2 Earnings Call Highlights

Key Points

3 of the Best Dividend Stocks to Buy in August 2026: https://g.foolcdn.com/editorial/images/881704/a-happy-person-holding-money-in-front-of-their-computer.jpg
3 of the Best Dividend Stocks to Buy in August 2026

Dividend stocks can be highly valuable investments to hold for the long term. In addition to dividend income, they have the potential to generate slow but modest gains over time. The problem these

"There are no new eras; excesses are never permanent." --Bob Farrell (Rule #3)Photo, wide shot, wide-angle lens, soft focus,  Pharmaceutical company, sunset photo at golden hour, photo by Peter Lik: https://oaidalleapiprodscus.blob.core.windows.net/private/org-IbuNdCATsFaPOITjFOv2kJh3/user-AXaxqjBUW45D8BadJEo9mUpW/img-TIgKJfhK8q44RPNTTsL9npu7.png?st=2023-05-08T05%3A58%3A04Z&se=2023-05-08T07%3A58%3A04Z&sp=r&sv=2021-08-06&sr=b&rscd=inline&rsct=image/png&skoid=6aaadede-4fb3-4698-a8f6-684d7786b067&sktid=a48cca56-e6da-484e-a814-9c849652bcb3&skt=2023-05-08T02%3A36%3A56Z&ske=2023-05-09T02%3A36%3A56Z&sks=b&skv=2021-08-06&sig=BDDjRcmCPf%2BH//HSxRGZYByMqOKev8lx0/Dhvka/lXk%3D
"There are no new eras; excesses are never permanent." --Bob Farrell (Rule #3)

TIPPING POINT: BUY LTPZ

TIPPING POINT: BUY LTPZ (July 31, 2026): As I had described in my recent postings, U.S. government debt has become unusually undervalued, with many U.S